• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核医学治疗中的剂量学里程碑。

Milestones in dosimetry for nuclear medicine therapy.

机构信息

The Joint Department of Physics, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, United Kingdom.

出版信息

Br J Radiol. 2022 Jul 1;95(1135):20220056. doi: 10.1259/bjr.20220056. Epub 2022 May 12.

DOI:10.1259/bjr.20220056
PMID:35451857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10996314/
Abstract

Nuclear Medicine therapy has reached a critical juncture with an unprecedented number of patients being treated and an extensive list of new radiopharmaceuticals under development. Since the early applications of these treatments dosimetry has played a vital role in their development, in both aiding optimisation and enhancing safety and efficacy. To inform the future direction of this field, it is useful to reflect on the scientific and technological advances that have occurred since those early uses. In this review, we explore how dosimetry has evolved over the years and discuss why such initiatives were conceived and the importance of maintaining standards within our practise. Specific milestones and landmark publications are highlighted and a thematic review and significant outcomes during each decade are presented.

摘要

核医学治疗已经到了一个关键的时刻,有大量的患者接受治疗,大量新的放射性药物正在开发中。自这些治疗方法的早期应用以来,剂量学在其发展中发挥了至关重要的作用,既有助于优化,又提高了安全性和疗效。为了为这一领域的未来发展提供信息,回顾一下自早期应用以来发生的科学技术进步是很有用的。在这篇综述中,我们探讨了剂量学多年来是如何发展的,并讨论了为什么会有这样的设想,以及在我们的实践中保持标准的重要性。我们强调了特定的里程碑和标志性出版物,并对每个十年的主题综述和重要结果进行了介绍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f553/10996314/ed0b89b50776/bjr.20220056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f553/10996314/ed0b89b50776/bjr.20220056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f553/10996314/ed0b89b50776/bjr.20220056.g001.jpg

相似文献

1
Milestones in dosimetry for nuclear medicine therapy.核医学治疗中的剂量学里程碑。
Br J Radiol. 2022 Jul 1;95(1135):20220056. doi: 10.1259/bjr.20220056. Epub 2022 May 12.
2
Dosimetry for Radiopharmaceutical Therapy: The European Perspective.放射性药物治疗剂量学:欧洲视角。
J Nucl Med. 2021 Dec;62(Suppl 3):73S-79S. doi: 10.2967/jnumed.121.262754.
3
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy.EANM 关于理事会指令 2013/59/Euratom(基本安全标准)第 56 条的立场文件,该指令适用于核医学治疗。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):67-72. doi: 10.1007/s00259-020-05038-9. Epub 2020 Oct 15.
4
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.EANM 指导文件:用于首次人体研究和早期临床试验的剂量学。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1268-1286. doi: 10.1007/s00259-024-06640-x. Epub 2024 Feb 17.
5
Biting the magic bullet: celebrating a decade of the EANM Dosimetry Committee.咬住神奇子弹:庆祝欧洲核医学与分子影像学会剂量测定委员会成立十周年
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):1-3. doi: 10.1007/s00259-013-2589-2.
6
Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine.精确剂量测定:迈向核医学良好临床实践的关键一步。
Nucl Med Commun. 2005 Jul;26(7):581-6. doi: 10.1097/01.mnm.0000169204.13754.e2.
7
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization.核医学治疗中的剂量学:当前的争议和对治疗优化的影响。
Q J Nucl Med Mol Imaging. 2021 Dec;65(4):327-332. doi: 10.23736/S1824-4785.21.03418-X. Epub 2021 Dec 9.
8
The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise.内照射与外照射剂量学之争:阿基里斯与乌龟的芝诺悖论。
Phys Med. 2024 Jan;117:103188. doi: 10.1016/j.ejmp.2023.103188. Epub 2023 Dec 2.
9
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities.放射性药物剂量测定的报销途径:现状与未来机遇。
J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S. doi: 10.2967/jnumed.121.262752.
10
Modern Radiopharmaceutical Dosimetry Should Include Robust Biodistribution Reporting.现代放射性药物剂量学应包括稳健的生物分布报告。
J Nucl Med. 2018 Oct;59(10):1507-1509. doi: 10.2967/jnumed.118.208603. Epub 2018 Mar 30.

引用本文的文献

1
Learning from the past: a century of accuracy, aspirations, and aspersions in brachytherapy.从过去中学习:近一百年近距离放射治疗的准确性、抱负和诽谤。
Br J Radiol. 2022 Dec 1;95(1140):20220500. doi: 10.1259/bjr.20220500. Epub 2022 Oct 1.

本文引用的文献

1
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.EANM 剂量学委员会关于 177Lu 标记的生长抑素受体和 PSMA 靶向配体剂量学的建议。
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1778-1809. doi: 10.1007/s00259-022-05727-7. Epub 2022 Mar 14.
2
Overview of commercial treatment planning systems for targeted radionuclide therapy.靶向放射性核素治疗的商业治疗计划系统概述。
Phys Med. 2021 Dec 2;92:52-61. doi: 10.1016/j.ejmp.2021.11.001.
3
EANM dosimetry committee series on standard operational procedures: a unified methodology for Tc-MAA pre- and Y peri-therapy dosimetry in liver radioembolization with Y microspheres.
欧洲核医学与分子影像学会剂量测定委员会标准操作程序系列:钇微球肝脏放射性栓塞治疗中锝-标记大聚合人血清白蛋白(Tc-MAA)治疗前及钇治疗期间剂量测定的统一方法。
EJNMMI Phys. 2021 Nov 12;8(1):77. doi: 10.1186/s40658-021-00394-3.
4
A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease.甲状腺辐射吸收剂量与放射性碘治疗格雷夫斯病患者反应关系的系统评价和荟萃分析。
Thyroid. 2021 Dec;31(12):1829-1838. doi: 10.1089/thy.2021.0302.
5
Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN).基于理事会指令 2013/59/EURATOM 和意大利法律 N. 101/2020 对核医学治疗进行剂量学优化。意大利医学物理学会 (AIFM) 和核医学学会 (AIMN) 的立场文件和建议。
Phys Med. 2021 Sep;89:317-326. doi: 10.1016/j.ejmp.2021.07.001. Epub 2021 Sep 25.
6
The internal dosimetry user group position statement on molecular radiotherapy.内部剂量学用户组关于分子放射治疗的立场声明。
Br J Radiol. 2021 Oct 1;94(1126):20210547. doi: 10.1259/bjr.20210547. Epub 2021 Aug 25.
7
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project.在MRTDosimetry项目中对定量Lu-177单光子发射计算机断层扫描/计算机断层扫描成像准确性的多中心、多国评估。
EJNMMI Phys. 2021 Jul 23;8(1):55. doi: 10.1186/s40658-021-00397-0.
8
BNMS position statement on molecular radiotherapy.BNMS关于分子放射治疗的立场声明。
Nucl Med Commun. 2021 Oct 1;42(10):1061-1063. doi: 10.1097/MNM.0000000000001458.
9
The Future of Molecular Radiotherapy Services in the UK.英国分子放射治疗服务的未来。
Clin Oncol (R Coll Radiol). 2021 Feb;33(2):137-143. doi: 10.1016/j.clon.2020.11.012. Epub 2020 Dec 1.
10
ICRP Publication 145: Adult Mesh-Type Reference Computational Phantoms.国际放射防护委员会第145号出版物:成人网状型参考计算人体模型。
Ann ICRP. 2020 Oct;49(3):13-201. doi: 10.1177/0146645319893605.